Financials
Financial year 2025
Injection Test from Oupeye, company number BE0737987282, closed financial year 2025 with a result of € 12,518 after tax. For that financial year Injection Test recorded a gross margin of € 35,456 and equity of € 67,547. Compared with financial year 2024, the result moved from € 2,710 to € 12,518. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on February 18, 2026.
€ 67,547
▲ 7% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 12,518
▲ € 9,808 vs 2024
Profit after tax over the fiscal year.
€ 35,861
▼ 59% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 8,000 paid out
64 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 28,089
▼ 31% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 2,090
▼ 75% vs 2024
Loans from banks and other lenders, long and short.
€ 2,727
▲ 22% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 6,605
▼ 43% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 26,930 | € 54,609 | € 69,171 | € 35,456 | ▼ 49% |
| Profit after taxes | € 16,806 | € 34,531 | € 2,710 | € 12,518 | ▲ € 9,808 |
| Equity | € 44,995 | € 68,319 | € 63,029 | € 67,547 | ▲ 7% |
| Total debts | € 34,423 | € 38,571 | € 29,014 | € 25,056 | ▼ 14% |
| Cash | € 51,883 | € 81,095 | € 86,935 | € 35,861 | ▼ 59% |
| Retained profit | € 39,995 | € 63,319 | € 58,029 | € 62,547 | ▲ 8% |
| Dividend | € 8,000 | € 11,207 | € 8,000 | € 8,000 | |
| Bank debt | € 20,625 | € 14,502 | € 8,324 | € 2,090 | ▼ 75% |
| Balance sheet total | € 79,418 | € 106,890 | € 143,668 | € 92,603 | ▼ 36% |
Key figures of Injection Test, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Injection Test?
What happened at Injection Test in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 12,518 (▲ € 9,808 vs 2024). Source: NBB ↗
- New establishment in Oupeye. KBO
- Joseph Rousseaux became a director. NBB
- Nicolas Rousseaux became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 16,806 profit in 2022 to € 12,518 profit in 2025.
Paid € 27,394 in corporate taxes since 2022.
Best year ever: 2023, with € 34,531 profit.
Paid out € 35,207 in dividends to the owners in total.
Management
Behind Injection Test are Joseph Rousseaux and Nicolas Rousseaux. Joseph Rousseaux is also behind I.P.I.C. PLASTIC.
Directors
According to the 2025 annual accounts
since 2019
Nicolas Rousseaux
Director
since 2019
Establishments
Establishment units
Physical locations of this company
Rue Boyou 52
4682 Oupeye
Rue Boyou 52 box bis
4682 Oupeye
Active since 1 December 2019
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0737.987.282
- VAT number
- BE 0737.987.282
- Registered office
- Rue Boyou 52, 4682 Oupeye
- Names & denominations
- Injection Test
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 22 November 2019
- Peppol
- Active · Active since 23 Oct 2025
- Activities · NACE
Vervaardiging van kunststoffen in primaire vormen
Vervaardiging van platen, vellen, buizen en profielen van kunststof